Globus Medical Inc (NYSE: GMED) is 2.20% higher on its value in year-to-date trading and has touched a low of $43.38 and a high of $62.88 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The GMED stock was last observed hovering at around $56.43 in the last trading session, with the day’s loss setting it -1.97%.
Currently trading at $54.46, the stock is 1.70% and 1.51% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.94 million and changing -3.49% at the moment leaves the stock 2.02% off its SMA200. GMED registered -7.44% loss for a year compared to 6-month gain of 1.15%. The firm has a 50-day simple moving average (SMA 50) of $4.70 and a 200-day simple moving average (SMA200) of $21.28.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -0.15% loss in the last 1 month and extending the period to 3 months gives it a 18.21%, and is -0.98% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.98% over the week and 2.57% over the month.
Globus Medical Inc (GMED) has around 5000 employees, a market worth around $7.37B and $1.57B in sales. Current P/E ratio is 46.76 and Fwd P/E is 16.48. Profit margin for the company is 7.83%. Distance from 52-week low is 25.53% and -13.39% from its 52-week high. The company has generated returns on investments over the last 12 months (2.73%).
Globus Medical Inc quarterly earnings per share for the current quarter are estimated at $0.57 with sales reaching $586.17M over the same period.The EPS is expected to grow by 15.98% this year, but quarterly earnings will post 57.10% year-over-year. Quarterly sales are estimated to grow 111.90% in year-over-year returns.
559 institutions hold shares in Globus Medical Inc (GMED), with institutional investors hold 97.45% of the company’s shares. The shares outstanding are 113.91M, and float is at 112.02M with Short Float at 5.16%. Institutions hold 96.66% of the Float.
The top institutional shareholder in the company is Blackrock Inc. with over 13.93 million shares valued at $829.47 million. The investor’s holdings represent 13.87% of the GMED Shares outstanding. As of Jun 29, 2023, the second largest holder is Vanguard Group Inc with 11.95 million shares valued at $711.6 million to account for 11.90% of the shares outstanding. The other top investors are Janus Henderson Group PLC which holds 7.67 million shares representing 7.64% and valued at over $456.72 million, while State Street Corporation holds 4.02% of the shares totaling 4.03 million with a market value of $240.22 million.
Globus Medical Inc (GMED) Insider Activity
A total of 5 insider transactions have happened at Globus Medical Inc (GMED) in the last six months, with sales accounting for 0 and purchases happening 5 times. The most recent transaction is an insider sale by Lemaitre Dan, the company’s Director. SEC filings show that Lemaitre Dan sold 43,450 shares of the company’s common stock on May 15 at a price of $56.98 per share for a total of $2.48 million. Following the sale, the insider now owns 10800.0 shares.
Globus Medical Inc (GMED): Who are the competitors?
One of the company’s main competitors (and peers) include Zimmer Biomet Holdings Inc. (ZBH) that is trading 1.68% up over the past 12 months.Stryker Corp. (SYK) lies in the list of competitors of the Globus Medical Inc and is 35.32% higher over the same period from GMEDAlphatec Holdings Inc. (ATEC) is -7.36% down on the 1-year trading charts.
